Sign in
CompletedNo phase

Antibiotic Resistance of Helicobacter Pylori in Nanjing: A Cross-Sectional Study

Key facts

Who runs it
Nanjing First Hospital, Nanjing Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
7,227 people enrolled
Started
1 Mar 2026
Ended
25 Mar 2026
Type of study
Observational
Treatments tested
  • Antimicrobial susceptibility testing
Record updated
9 April 2026

Who can take part

Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Patients who visited the Gastroenterology Department of Nanjing First Hospital and underwent gastroscopy with H. pylori culture and genetic testing between 2018 and 2024
  • Positive for H. pylori by at least one diagnostic method (13C-urea breath test, rapid urease test, or histopathology)
  • Provision of general written informed consent for the use of gastroscopy and specimen data in research
  • Availability of complete medical records and laboratory test results

Who cannot take part

  • Withdrawal of informed consent; use of antibiotics, proton pump inhibitors, H2-receptor antagonists, or bismuth agents within four weeks prior to gastroscopy
  • History of gastric surgery
  • Incomplete medical records or test results precluding evaluation
  • Other factors deemed by the investigator to render the participant unsuitable for inclusion

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to provide an updated analysis of the resistance patterns of H. pylori in the Nanjing region, with a focus on characterizing the current status of phenotypic and genotypic resistance to these six antimicrobial agents. The findings are expected to offer a scientific basis for the rapid diagnosis and personalized treatment of H. pylori infection.

Treatments tested

  • Antimicrobial susceptibility testing

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
9 April 2026